Finally, Kania and Klein [51] conclude with links between Eph-ephrin signaling and disease, with a robust decade of research connecting the pathway to tumor growth, pathological angiogenesis, and malignant cell migration, but also to neurological disorders such as lateral sclerosis or Alzheimer’s disease. This evidence concerns the gene EPHA1 and lateral sclerosis.